Accellacare is a clinical research site located in Ames, Iowa, United States 50010.
Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.
Accellacare has participated in 3 clinical trials with 1 currently active.
Therapeutic areas: COVID-19, Focal Epilepsy.
Sponsors: Pfizer, Biohaven Therapeutics Ltd..
Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Accellacare has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Accellacare has 3 clinical trials on record, with 1 currently active. Their work covers COVID-19, Focal Epilepsy.
Accellacare has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.